journal article·2011-05

Biological behavior of pre‐osteoblasts on natural hydroxyapatite: A study of signaling molecules from attachment to differentiation

Willian F. Zambuzzi, Carmen V. Ferreira, José M. Granjeiro, Hiroshi Aoyama

Publisher page

Abstract

Abstract Several biomaterials have been widely used in bone regeneration in both orthopedic and oral surgeries. However, it is poorly understood how these biomaterials alter osteoblast phenotype. It prompted us to examine the involvement of signaling proteins during preosteoblast adhesion (attachment), proliferation, and differentiation on natural hydroxyapatite (HA) from bovine bone. Our results indicated that natural HA is able to promote osteoblast adhesion, proliferation, and differentiation. The osteoblast/HA interaction requires phosphorylation of tyrosine residues of focal adhesion kinase, Src, and Paxillin upon integrin activation, which culminates in the control of cofilin phosphorylation (at serine 03) via rac‐1 activation. In part, these signaling pathways are responsible for actin‐rearrangement, responsible to adapt cell‐shape on HA particles. In regarding to osteoblast differentiation, we showed that natural HA favored extracellular matrix remodeling by stimulating matrix metalloproteinase activities and alkaline phosphatase activity. Overall, this study demonstrates that osteoblast response toward bovine bone HA is initially mediated by activation of focal adhesion components, culminating on actin‐rearrangement executed by cofilin activation via rac‐1. Moreover, bovine bone HA provided an excellent microenvironment for osteoblast activity, since adhesion to differentiation. © 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A:, 2011.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Bone and Dental Protein Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (48)

Show source-provided references
1. 10.1002/jor.110005011410.1002/jor.1100050114 ↗
2. The use of calcium hydroxyapatite ceramic in bone tumour surgery10.1302/0301-620X.72B2.2155908 ↗
3. 10.1302/0301-620X.82B8.1119410.1302/0301-620X.82B8.11194 ↗
4. 10.1002/bies.2063610.1002/bies.20636 ↗
5. 10.1016/S0076-6879(07)26008-210.1016/S0076-6879(07)26008-2 ↗
6. 10.1038/ncb0807-85810.1038/ncb0807-858 ↗
7. 10.1016/j.dental.2009.01.09510.1016/j.dental.2009.01.095 ↗
8. 10.1016/j.cell.2007.05.04110.1016/j.cell.2007.05.041 ↗
9. 10.1016/j.yexcr.2007.07.00210.1016/j.yexcr.2007.07.002 ↗
10. 10.1111/j.1600-0765.1993.tb02113.x10.1111/j.1600-0765.1993.tb02113.x ↗
11. 10.1080/0001635060096364010.1080/00016350600963640 ↗
12. 10.1111/j.1582-4934.2007.00103.x10.1111/j.1582-4934.2007.00103.x ↗
13. 10.1016/j.tcb.2008.02.00210.1016/j.tcb.2008.02.002 ↗
14. 10.1074/jbc.274.48.3382710.1074/jbc.274.48.33827 ↗
15. 10.1016/S0962-8924(01)02008-610.1016/S0962-8924(01)02008-6 ↗
16. 10.1590/S0103-6440200600040000210.1590/S0103-64402006000400002 ↗
17. 10.1590/S1678-7757200500040001310.1590/S1678-77572005000400013 ↗
18. 10.1590/S1806-8324200800010000210.1590/S1806-83242008000100002 ↗
19. 10.1007/s11010-008-9951-x10.1007/s11010-008-9951-x ↗
20. Microelisa reader quantitation of fixed, stained, solubilized cells in microtitre dishes
21. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
22. 10.1016/j.canlet.2007.08.02410.1016/j.canlet.2007.08.024 ↗
23. 10.1016/j.biochi.2008.01.01110.1016/j.biochi.2008.01.011 ↗
24. 10.1016/0003-2697(72)90094-210.1016/0003-2697(72)90094-2 ↗
25. 10.1159/00018550610.1159/000185506 ↗
26. 10.1902/jop.2001.72.2.15210.1902/jop.2001.72.2.152 ↗
27. 10.1016/S0109-5641(03)00024-110.1016/S0109-5641(03)00024-1 ↗
28. 10.1016/j.dental.2006.11.02310.1016/j.dental.2006.11.023 ↗
29. 10.1016/j.dental.2007.03.00110.1016/j.dental.2007.03.001 ↗
30. 10.1016/j.dental.2008.09.00710.1016/j.dental.2008.09.007 ↗
31. A transmembrane‐anchored chimeric focal adhesion kinase is constitutively activated and phosphorylated at tyrosine residues identical to pp125FAK10.1016/S0021-9258(17)32031-8 ↗
32. 10.1074/jbc.270.28.1699510.1074/jbc.270.28.16995 ↗
33. 10.1126/science.286.5442.117210.1126/science.286.5442.1172 ↗
34. 10.1016/j.biomaterials.2007.06.02810.1016/j.biomaterials.2007.06.028 ↗
35. 10.1073/pnas.89.11.519210.1073/pnas.89.11.5192 ↗
36. 10.1016/j.biomaterials.2004.01.06210.1016/j.biomaterials.2004.01.062 ↗
37. 10.1002/jcb.2247910.1002/jcb.22479 ↗
38. 10.1016/j.biochi.2010.01.00210.1016/j.biochi.2010.01.002 ↗
39. 10.1111/j.1525-1594.2008.00547.x10.1111/j.1525-1594.2008.00547.x ↗
40. 10.1111/j.1600-0501.2008.01642.x10.1111/j.1600-0501.2008.01642.x ↗
41. 10.1038/3173510.1038/31735 ↗
42. 10.1002/jbm.a.3170110.1002/jbm.a.31701 ↗
43. 10.1016/j.abb.2008.03.02410.1016/j.abb.2008.03.024 ↗
44. 10.1016/S0142-9612(00)00269-610.1016/S0142-9612(00)00269-6 ↗
45. 10.1016/0304-4165(84)90046-110.1016/0304-4165(84)90046-1 ↗
46. 10.1016/j.bone.2003.08.01110.1016/j.bone.2003.08.011 ↗
47. 10.1038/416744a10.1038/416744a ↗
48. 10.1016/j.tripleo.2005.10.05410.1016/j.tripleo.2005.10.054 ↗